Quest Diagnostics Inc (DGX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Quest Diagnostics Inc (DGX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7243
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:110
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Quest Diagnostics Inc (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a chain of laboratories and company-owned patient service centers. It offers comprehensive range of services including clinical testing with gene-based and other esoteric tests, anatomic pathology services, life insurer services, clinical trial testing, healthcare information technology and diagnostic products. The company caters to managed care organizations and other health insurance providers, clinicians, hospitals, retail healthcare providers, laboratories and governmental agencies. Diagnostics, along with its subsidiaries and branches, operates in North America, Asia Pacific, South America, and Europe. Quest Diagnostics is headquartered in Madison, New Jersey, the US.

Quest Diagnostics Inc (DGX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Quest Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 9
Quest Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Quest Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 11
Quest Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Quest Diagnostics Inc, Medical Equipment, Deal Details 15
Asset Purchase 15
Quest Diagnostics to Acquire US Laboratory Services Business from Oxford Immunotec for USD170 Million 15
Quest Diagnostics Acquires Assets from California Laboratory Associates 17
Venture Financing 18
Clinical Genomics Technologies Raises USD26 Million in Venture Financing 18
Clinical Genomics Technologies Raises USD15 Million in Series A Financing Round 20
Partnerships 21
Vermillion Enters into Licensing Agreement with Quest Diagnostics 21
Clinical Genomics Enters into Licensing Agreement with CSIRO 22
Illumina Enters Into Licensing Agreement With Quest Diagnostics 23
Life Technologies Enters Into Licensing Agreement With Quest Diagnostics For Development Of Molecular Tests 24
Quest Diagnostics Enters Into Licensing Agreement With Transgenomic For Opioid Therapy Genetic Test 25
Matrix-Bio Enters Into Licensing Agreement With Quest Diagnostics For Metabolomic Biomarkers 26
Clinical Genomics Enters Into Licensing Agreement With Quest Diagnostics For Colon Cancer Markers 27
Augurex Life Sciences Enters Into Licensing Agreement With Quest Diagnostics For 14-3-3n Biomarker 28
Clinical Genomics Partners with Memorial Sloan Kettering Cancer Center 29
Biocept to Form Partnership with Quest Diagnostics Mexico 30
DermTech Enters into Agreement with Dermpath Diagnostics 31
Commonwealth Labs Enters into Agreement with Quest Diagnostics for IBSchek 32
Genomic Vision Extends Agreement with Quest Diagnostics 33
Thermo Fisher Scientific Enters Into Co-Marketing And Distribution Agreement With Quest Diagnostics 34
Genomic Vision Extends Co-Development Agreement With Quest Diagnostics 35
Quest Diagnostics Enters Into Co-Development Agreement With Hologic 36
PrimeraDx Enters Into Co-Development Agreement With Quest Diagnostics 37
Quest Diagnostics Enters Into Technology Integration Agreement With Appian 38
Quest Diagnostics Enters Into Agreement With Natera To Offer Panorama, Non-Invasive Prenatal Screening Test 39
Apenimed Enters Into Technology Integration Agreement With Quest Diagnostics 40
RedHill Biopharma Enters Into Co-Development Agreement With Quest Diagnostics To Develop MAP Test For Crohn’s Disease 41
Debt Offering 42
Quest Diagnostics Raises USD500 Million in Public Offering of 3.45% Senior Notes due 2026 42
Quest Diagnostics Raises USD600 Million in Public Offering of Senior Notes Due 2025 44
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2045 46
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2020 48
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2024 For US$300 Million 50
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2019 For US$300 Million 51
Asset Transactions 52
Strand Life Sciences to Acquire India Diagnostics Business from Quest Diagnostics 52
DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics 53
Acquisition 55
Quest Diagnostics Acquires ReproSource 55
Quest Diagnostics Acquires Shiel Medical from Fresenius Medical 56
Quest Diagnostics Acquires Cleveland HeartLab from Cleveland Clinic and Advantage Capital 58
Quest Diagnostics May Sell itself 60
Spectra Labs To Acquire Shiel Medical Labs 61
Quest Diagnostics Acquires ConVerge Diagnostic Services From Water Street Healthcare 62
Clinical Genomics Acquires Enterix From Quest Diagnostics 63
Quest Diagnostics Completes Sale Of HemoCue To Radiometer Medical For US$300 Million 64
Access Genetics Acquires OralDNA Labs From Quest Diagnostics 66
Quest Diagnostics Completes Acquisition Of S.E.D. Medical Labs From Lovelace Health 67
Quest Diagnostics Inc – Key Competitors 68
Quest Diagnostics Inc – Key Employees 69
Quest Diagnostics Inc – Locations And Subsidiaries 70
Head Office 70
Other Locations & Subsidiaries 70
Joint Venture 73
Recent Developments 74
Strategy And Business Planning 74
May 24, 2018: UnitedHealthcare Establishes Long-Term Strategic Partnership with Quest Diagnostics 74
Jan 26, 2017: Quest Diagnostics Partners With Montefiore Health System to Deliver High-Value, Innovative Laboratory Services 75
Financial Announcements 76
Jul 24, 2018: Quest Diagnostics Reports Second Quarter 2018 Financial Results 76
Apr 19, 2018: Quest Diagnostics Reports First Quarter 2018 Financial Results 77
Feb 01, 2018: Quest Diagnostics Reports Fourth Quarter And Full Year 2017 Financial Results; Provides Guidance For Full Year 2018; Increases Dividend 11% To $0.50 Per Quarter 78
Oct 19, 2017: Quest Diagnostics Reports Third Quarter 2017 Financial Results 80
Jul 25, 2017: Quest Diagnostics Reports Second Quarter 2017 Financial Results, Raises 2017 Financial Outlook 81
Apr 20, 2017: Quest Diagnostics Reports First Quarter 2017 Financial Results, Raises 2017 Financial Outlook 82
Jan 26, 2017: Quest Diagnostics Reports Fourth Quarter And Full Year 2016 Financial Results; Provides Guidance For Full Year 2017 83
Corporate Communications 84
Aug 16, 2018: Quest Diagnostics earns gold status in American Heart Association’s workplace health achievement index 84
May 17, 2018: Quest Diagnostics adds Helen Torley to Board of Directors 85
May 07, 2018: Forbes Names Quest Diagnostics One of America’s Best Large Employers 86
Jan 30, 2018: ChartMaxx from Quest Diagnostics Receives Document Management & Imaging Category Leader award in the 2018 ‘Best in KLAS: Software & Services Report’ 87
Legal and Regulatory 88
Dec 11, 2017: Quest Diagnostics supports suit against HHS charging that CMS ignored congressional intent in implementing new clinical lab payment system 88
Jun 15, 2017: Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation 89
Government and Public Interest 90
Nov 20, 2017: Quest Diagnostics Provides Update on Impact of Final 2018 Medicare Payment Rates for Clinical Laboratory Tests 90
Product News 91
Jun 23, 2018: One Third of Participants in a Workforce Study Reduce Risk for Diabetes after Employer Wellness Screening and Behavioral Counseling, Finds Quest Diagnostics Study 91
Jul 19, 2017: Quest Diagnostics Launches QHerit, a Pan-Ethnic Genetic Screening Panel Aligned with New Medical Guidelines 92
Feb 16, 2017: Quest Diagnostics: Harvard Pilgrim Health Care Partners with Physicians to Close Costly Gaps in Care 93
Other Significant Developments 94
Oct 10, 2018: Quest Diagnostics Launches the Global Diagnostics Network (GDN) to Improve Healthcare by Increasing Access to Diagnostic Insights Around the World 94
Sep 26, 2018: Quest Diagnostics partners With RMC Health System to deliver high-value innovative laboratory services 95
Jul 30, 2018: New quest diagnostics data shows lyme disease prevalence increasing and is now present in new U.S. states 96
Jul 17, 2018: Quest Diagnostics: New Study Reveals Stalled Progress Toward Value-Based Care 98
Jul 09, 2018: LabFinder.com Adds Quest Diagnostics to Roster of Subscribers 100
May 23, 2018: Physicians Lack the Time and Tools to Discover Hidden Risks in Patients with Chronic Conditions, Finds Study from Quest Diagnostics 101
Sep 27, 2017: Quest Diagnostics Provides Update On Impact to Third Quarter Financial Results from Hurricanes 103
Sep 26, 2017: Rx Savings Solutions Helps Quest Diagnostics’ Health Plan Members Save Money On Prescription Drugs 104
Sep 22, 2017: Quest Diagnostics Responds to Proposed PAMA 2018 Medicare Payment Rates for Clinical Laboratory Tests 105
Sep 07, 2017: Quest Diagnostics Moves to Convenient Nonfasting Cholesterol Testing with Improved Method for Assessing Heart Disease Risk and Aiding Treatment Decisions 106
Aug 30, 2017: MDI Solutions selected to provide Cloverleaf Secure Courier implementation and training services 108
Jan 18, 2017: Quest Diagnostics Launches Nation’s First Hepatitis B Virus Quantitative Test to Help Assess Response to Antiviral Therapy 109
Appendix 110
Methodology 110
About GlobalData 110
Contact Us 110
Disclaimer 110

List of Tables
Quest Diagnostics Inc, Medical Equipment, Key Facts, 2017 2
Quest Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Quest Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 9
Quest Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Quest Diagnostics Inc, Deals By Market, 2012 to YTD 2018 11
Quest Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Quest Diagnostics to Acquire US Laboratory Services Business from Oxford Immunotec for USD170 Million 15
Quest Diagnostics Acquires Assets from California Laboratory Associates 17
Clinical Genomics Technologies Raises USD26 Million in Venture Financing 18
Clinical Genomics Technologies Raises USD15 Million in Series A Financing Round 20
Vermillion Enters into Licensing Agreement with Quest Diagnostics 21
Clinical Genomics Enters into Licensing Agreement with CSIRO 22
Illumina Enters Into Licensing Agreement With Quest Diagnostics 23
Life Technologies Enters Into Licensing Agreement With Quest Diagnostics For Development Of Molecular Tests 24
Quest Diagnostics Enters Into Licensing Agreement With Transgenomic For Opioid Therapy Genetic Test 25
Matrix-Bio Enters Into Licensing Agreement With Quest Diagnostics For Metabolomic Biomarkers 26
Clinical Genomics Enters Into Licensing Agreement With Quest Diagnostics For Colon Cancer Markers 27
Augurex Life Sciences Enters Into Licensing Agreement With Quest Diagnostics For 14-3-3n Biomarker 28
Clinical Genomics Partners with Memorial Sloan Kettering Cancer Center 29
Biocept to Form Partnership with Quest Diagnostics Mexico 30
DermTech Enters into Agreement with Dermpath Diagnostics 31
Commonwealth Labs Enters into Agreement with Quest Diagnostics for IBSchek 32
Genomic Vision Extends Agreement with Quest Diagnostics 33
Thermo Fisher Scientific Enters Into Co-Marketing And Distribution Agreement With Quest Diagnostics 34
Genomic Vision Extends Co-Development Agreement With Quest Diagnostics 35
Quest Diagnostics Enters Into Co-Development Agreement With Hologic 36
PrimeraDx Enters Into Co-Development Agreement With Quest Diagnostics 37
Quest Diagnostics Enters Into Technology Integration Agreement With Appian 38
Quest Diagnostics Enters Into Agreement With Natera To Offer Panorama, Non-Invasive Prenatal Screening Test 39
Apenimed Enters Into Technology Integration Agreement With Quest Diagnostics 40
RedHill Biopharma Enters Into Co-Development Agreement With Quest Diagnostics To Develop MAP Test For Crohn's Disease 41
Quest Diagnostics Raises USD500 Million in Public Offering of 3.45% Senior Notes due 2026 42
Quest Diagnostics Raises USD600 Million in Public Offering of Senior Notes Due 2025 44
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2045 46
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2020 48
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2024 For US$300 Million 50
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2019 For US$300 Million 51
Strand Life Sciences to Acquire India Diagnostics Business from Quest Diagnostics 52
DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics 53
Quest Diagnostics Acquires ReproSource 55
Quest Diagnostics Acquires Shiel Medical from Fresenius Medical 56
Quest Diagnostics Acquires Cleveland HeartLab from Cleveland Clinic and Advantage Capital 58
Quest Diagnostics May Sell itself 60
Spectra Labs To Acquire Shiel Medical Labs 61
Quest Diagnostics Acquires ConVerge Diagnostic Services From Water Street Healthcare 62
Clinical Genomics Acquires Enterix From Quest Diagnostics 63
Quest Diagnostics Completes Sale Of HemoCue To Radiometer Medical For US$300 Million 64
Access Genetics Acquires OralDNA Labs From Quest Diagnostics 66
Quest Diagnostics Completes Acquisition Of S.E.D. Medical Labs From Lovelace Health 67
Quest Diagnostics Inc, Key Competitors 68
Quest Diagnostics Inc, Key Employees 69
Quest Diagnostics Inc, Subsidiaries 70
Quest Diagnostics Inc, Joint Venture 73

List of Figures
Quest Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Quest Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Quest Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Quest Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 9
Quest Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Quest Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 11

★海外企業調査レポート[Quest Diagnostics Inc (DGX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MGIC Investment Corporation:企業の戦略・SWOT・財務分析
    SummaryMGIC Investment Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • HandR Block, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' HandR Block, Inc. Mergers and A …
  • Universal Display Corporation (OLED):企業財務及び戦略的SWOT分析
    Summary Universal Display Corporation (UDC) is a clean technology company that conducts research, develops and markets organic light emitting diode, technologies and materials. The company offers PHOLED materials which are used in making OLED displays and lighting panels. It provides technologies su …
  • sanofi-aventis U.S. LLC.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' sanofi-aventis U.S. LLC. Merger …
  • Magnolia Petroleum Plc (MAGP):企業概要、財務及び戦略的SWOT分析
    Summary Magnolia Petroleum Plc (Magnolia Petroleum) is an oil and gas production company. The company acquires, exploits, and develops oil and gas properties in the US. It has interests in about 150 producing properties and over 13,500 net mineral acres in two major project areas, including Bakken s …
  • AB Industrivarden (INDU A):企業財務及び戦略的SWOT分析
    Summary AB Industrivarden (Industrivarden) is an investment holding company that offers investment management solutions. Its services include active ownership and investment operations. The company invests in listed Nordic companies with large and medium market capitalization. Industrivarden provide …
  • Fuerst Day Lawson Ltd:企業の戦略・SWOT・財務情報
    Fuerst Day Lawson Ltd - Strategy, SWOT and Corporate Finance Report Summary Fuerst Day Lawson Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • BBCN Bancorp, Inc.:企業の戦略・SWOT・財務分析
    SummaryBBCN Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • Phoenix Brands LLC:企業の戦略・SWOT・財務分析
    SummaryPhoenix Brands LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • CRH Medical Corporation (CRH):企業のM&A・提携動向(医療機器分野)
    Summary CRH Medical Corporation (CRH Medical) is a medical device company that offers treatments. The company offers CRH O’Regan System a hemorrhoid technology for treating hemorrhoid. It provides topical ointments and creams including preparation H for the treatment of hemorrhoid. CRH Medical offer …
  • PT Resource Alam Indonesia Tbk (KKGI):企業財務及び戦略的SWOT分析
    Summary PT Resource Alam Indonesia Tbk (PT Resource), formerly PT Kurnia Kapuas Utama Glue Industries is a subsidiary of The Bumi Raya Utama Group is a mining company that develops, explores, produces and sells coal properties. The company’s services include exploration and production of coal resour …
  • Oystar Holding GmbH:企業の戦略・SWOT・財務分析
    SummaryOystar Holding GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fin …
  • Acme Resources Inc. (ARI):企業概要、財務及び戦略的SWOT分析
    Summary Acme Resources Inc. (Acme Resources) is a mineral exploration company. The company provides acquisition, exploration, and advancement of mineral properties in Canada. Its products include uranium, copper, gold, and rare earth elements. The company explores and develops uranium and base metal …
  • Sopra Steria Group:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Sopra Steria Group Mergers and …
  • Suncorp Group Ltd:企業の戦略・SWOT・財務情報
    Suncorp Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Suncorp Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Lumera Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Lumera Corporation Mergers and …
  • Genetic Analysis AS:(医療機器分野)企業M&A及び提携動向
    Summary Genetic Analysis AS (Genetic Analysis) is a molecular diagnostic company. The company focuses in the molecular diagnostics of diseases related to gut imbalances. It has developed DNA-based GA-map technology. Genetic Analysis’s products include GA-map MFA, GA-map CORE, GA-map IBD, GA-map IBS …
  • E.T. Browne Drug Co., Inc. :企業の戦略・SWOT・財務分析
    SummaryE.T. Browne Drug Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Universal Solution Systems Inc. (3390):企業概要、財務及び戦略的SWOT分析
    Summary Universal Solution Systems Inc. (Universal Solution) is an information technology service provider. The company provides application services and e-commerce services. It operates chain stores and restaurants for ASP solutions service, and sells mobile phones, smart phones, tablet devices. Un …
  • Cockatoo Coal Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Cockatoo Coal Limited Mergers a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆